Rgenix

Rgenix

Rgenix is a cancer treatment company founded in 2010 by Shahram Seyedin-Noor, Saeed Tavazoie, Masoud Tavazoie and Sohail Tavazoie.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

October 2018
Rgenix raises a $40,000,000 series C round from Lepu Medical, Novo Holdings A/S, Oceanpine Capital, Partnership Fund for New York City, WuXi AppTec and Sofinnova Partners.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Rgenix, Inc funding round, October 2018
40,000,000
October 2018
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Shahram Seyedin-Noor

Founder

Steve Mohebi

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
May 29, 2020
BioSpace
RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today it is presenting data showing clinical activity in patients with advanced colorectal (CRC) tumors from a clinical trial of RGX-202, a first-in-class small molecule that inhibits a novel canc
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.